Prohledat tento blog

18.08.19

Risk Factors for Cancer | Did You Know?

Žádné komentáře:

Okomentovat

PD-1 Blockade in Advanced Adrenocortical Carcinoma

The authors of this phase II study evaluated the activity of pembrolizumab in 39 patients with advanced adrenocortical carcinoma. The objec...